The NSW Cannabis Medicines Advisory Service
The Service is available to all NSW medical practitioners including general practitioners, and other medical specialists, as well as pharmacists, nurses and other health professionals and services.
Medical practitioners can contact the Service Monday to Friday 9:00am to 5:00pm by email
A Therapeutic Goods Administration (TGA) review of the current clinical evidence for cannabis medicines in paediatric and adult epilepsies, multiple sclerosis, nausea and vomiting resulting from chemotherapy and HIV/AIDS therapy, pain, and palliative care is available on the TGA website
The Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), based at the University of Newcastle, received funding from the NSW Government to develop practical NSW Cannabis Medicines Prescribing Guidance to provide interim information to support NSW medical practitioners in prescribing cannabis medicines to patients for conditions where cannabinoids are perceived to have some benefit.
documents have been developed and are available on ACRE’s website